Trial Outcomes & Findings for Fixed Lingual Mandibular Growth Modificator (NCT NCT01853137)
NCT ID: NCT01853137
Last Updated: 2020-11-12
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
43 participants
Primary outcome timeframe
8 months
Results posted on
2020-11-12
Participant Flow
patients were recruited from those referred to the department of Orthodontics at the University of Damascus between May 2009 and June 2011.
Participant milestones
| Measure |
FLMGM Treatment Group
Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance
|
Untreated Class II Control Group
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
18
|
|
Overall Study
COMPLETED
|
21
|
17
|
|
Overall Study
NOT COMPLETED
|
4
|
1
|
Reasons for withdrawal
| Measure |
FLMGM Treatment Group
Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance
|
Untreated Class II Control Group
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
4
|
1
|
Baseline Characteristics
Fixed Lingual Mandibular Growth Modificator
Baseline characteristics by cohort
| Measure |
FLMGM Treatment Group
n=25 Participants
Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance
|
Untreated Class II Control Group
n=18 Participants
|
Total
n=43 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
25 Participants
n=93 Participants
|
18 Participants
n=4 Participants
|
43 Participants
n=27 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Age, Continuous
|
13.2 years
STANDARD_DEVIATION 0.9 • n=93 Participants
|
12.5 years
STANDARD_DEVIATION 2.1 • n=4 Participants
|
13.0 years
STANDARD_DEVIATION 1.3 • n=27 Participants
|
|
Sex: Female, Male
Female
|
14 Participants
n=93 Participants
|
10 Participants
n=4 Participants
|
24 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
11 Participants
n=93 Participants
|
8 Participants
n=4 Participants
|
19 Participants
n=27 Participants
|
|
Region of Enrollment
Syrian Arab Republic
|
25 participants
n=93 Participants
|
18 participants
n=4 Participants
|
43 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: 8 monthsOutcome measures
| Measure |
FLMGM Treatment Group
n=21 Participants
Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance
|
Untreated Class II Control Group
n=17 Participants
This is a group of patients classified as Class II patients but they are not treated during the observation period of this study
|
|---|---|---|
|
Total Mandibular Length (Co-Gn)
|
3.51 mm
Standard Deviation 1.37
|
1.18 mm
Standard Deviation 1.13
|
SECONDARY outcome
Timeframe: 8 monthsOutcome measures
| Measure |
FLMGM Treatment Group
n=21 Participants
Fixed Lingual Mandibular Growth Modificator (FLMGM) : Novel Class II functional appliance, a fixed version of double-plate appliance
|
Untreated Class II Control Group
n=17 Participants
This is a group of patients classified as Class II patients but they are not treated during the observation period of this study
|
|---|---|---|
|
Overjet Reduction
|
-3.32 mm
Standard Deviation 2.86
|
0.74 mm
Standard Deviation 0.94
|
Adverse Events
FLMGM Treatment Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Untreated Class II Control Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place